Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis
2 other identifiers
interventional
31
1 country
1
Brief Summary
The study is to lay the groundwork for non invasive imaging of the GI tract and the brain gut interaction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
February 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedApril 12, 2024
April 1, 2024
6.4 years
December 19, 2019
April 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric peristalsis
Compare 3D gastric peristalsis progression before \& after test meals in healthy volunteers and patients with gastroparesis
Baseline
Secondary Outcomes (2)
Contraction frequency
Baseline
Pylorus transit
Baseline
Study Arms (2)
Healthy Volunteer
OTHERThis arm will enroll healthy volunteers as controls
Gastroparesis Subjects
OTHERThis arm will enroll a) patients with gastroparesis from type 1 diabetes and b) patients with gastroparesis from vagus nerve trauma
Interventions
Eligibility Criteria
You may qualify if:
- Healthy volunteers from 18 to 65 years of age
You may not qualify if:
- Contraindication to MR scanning: pregnancy, implanted gastric stimulator, neural stimulator, implanted cardiac pacemaker, auto-defibrillator, cochlear implant, ocular foreign body (e.g. metal shavings), pain pump, insulin pump or any pre-existing eye conditions.
- Presence of gastroparesis symptoms, such as nausea, emesis, early satiety, effortless regurgitation, post-prandial fullness and pain, and/or postprandial epigastric pain.
- Prior diagnosis of the upper GI disorders, including gastroparesis, gastric or duodenal ulcer, gastric outlet obstruction, acute or chronic pancreatitis, large hiatal or paraesophageal hernia, small intestinal bacterial overgrowth, celiac disease, Crohn's disease.
- Prior systemic disorders associated with GI neuromuscular disorder listed in Appendix B.
- Taking medications that can effect GI motility, including opiate, metoclopramide, dopamine agonist for Parkinson or restless leg syndrome, anticholinergics.
- Prior brain or abdominal surgery (except cholecystectomy or appendectomy).
- Prior diagnosis of central nervous system illness, neurological lesion, a psychiatric history, or recurrent migraines that require medication.
- Uncontrolled medical problems, such as hypertension, pulmonary or airway disease, heart failure, or coronary artery disease.
- Allergy to pineapple.
- Presence of dysphagia.
- Unable to give own informed consent.
- GASTROPARESIS PATIENTS
- Patients with gastroparesis from 18 to 65 years of age.
- Symptoms of gastroparesis of at least 12 weeks duration with varying degrees of nausea, emesis, early satiety, effortless regurgitation, post-prandial fullness and pain, and/or postprandial epigastric pain.
- Abnormal 4-hour gastric emptying scintigraphy within the last 6 months \>60% retention at 2 hrs and/or \>10% retention at 4 hrs.
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana University School of Medicinelead
- Purdue Universitycollaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John M Wo, MD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of GI Motility and Neurogastroenterology Unit
Study Record Dates
First Submitted
December 19, 2019
First Posted
February 24, 2020
Study Start
August 1, 2019
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
April 12, 2024
Record last verified: 2024-04